Greystone Financial Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Greystone Financial Group's BMY Position: Q3 2026 in Review
Greystone Financial Group opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 84,722 shares worth $5.29M. The stake represents 1.47% of the portfolio and ranks #32 among its holdings. This is a return to the name: Greystone Financial Group previously reported a position in BMY as recently as Q1 2025.
Greystone Financial Group first reported a position in BMY in Q1 2021 and has held it in 9 quarters since. The position peaked at $9.8M in Q1 2025. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Greystone Financial Group held 84,722 shares of Bristol-Myers Squibb worth $5.29M as of Q3 2026.
- Bristol-Myers Squibb was a new Greystone Financial Group position in Q3 2026.
- Bristol-Myers Squibb made up 1.47% of Greystone Financial Group's portfolio in Q3 2026, its #32 holding.
- Greystone Financial Group first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 9 quarters since.
- Greystone Financial Group's Bristol-Myers Squibb position peaked at $9.8M in Q1 2025.
- 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Greystone Financial Group's 13F filing for Q3 2026, filed 26 Oct 2026.